ChIP-nexus enables improved detection of in vivo transcription factor binding footprints
Q He, J Johnston, J Zeitlinger - Nature biotechnology, 2015 - nature.com
Understanding how eukaryotic enhancers are bound and regulated by specific combinations
of transcription factors is still a major challenge. To better map transcription factor binding …
of transcription factors is still a major challenge. To better map transcription factor binding …
Zelda overcomes the high intrinsic nucleosome barrier at enhancers during Drosophila zygotic genome activation
The Drosophila genome activator Vielfaltig (Vfl), also known as Zelda (Zld), is thought to
prime enhancers for activation by patterning transcription factors (TFs). Such priming is …
prime enhancers for activation by patterning transcription factors (TFs). Such priming is …
A global change in RNA polymerase II pausing during the Drosophila midblastula transition
K Chen, J Johnston, W Shao, S Meier, C Staber… - Elife, 2013 - elifesciences.org
10.7554/eLife.00861.001 Massive zygotic transcription begins in many organisms during the
midblastula transition when the cell cycle of the dividing egg slows down. A few genes are …
midblastula transition when the cell cycle of the dividing egg slows down. A few genes are …
Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety
…, MJ Baird, HA Schneier, JM Johnston - Official journal of the …, 2012 - journals.lww.com
… the trial: Jeffrey Johnston and Bernard Lavins; assisted in the interpretation of data and
critical revision of the manuscript for important intellectual content: Jeffrey Johnston, Bernard …
critical revision of the manuscript for important intellectual content: Jeffrey Johnston, Bernard …
A case study in biomimetic total synthesis: polyolefin carbocyclizations to terpenes and steroids
RA Yoder, JN Johnston - Chemical reviews, 2005 - ACS Publications
Without exception, the most complex organic architectures have been produced by natural
organisms. The finding that many of these can be both selective and potent disruptors of …
organisms. The finding that many of these can be both selective and potent disruptors of …
The causal role for genital ulcer disease as a risk factor for transmission of human immunodeficiency virus: an application of the Bradford Hill criteria
MC Dickerson, J Johnston, TE Delea… - Sexually transmitted …, 1996 - journals.lww.com
Study Design: Case-control, cross-sectional, and cohort studies that examined the
association between HIV seroconversion and GUD were chosen from the literature. Twenty-seven …
association between HIV seroconversion and GUD were chosen from the literature. Twenty-seven …
A 12-week, randomized, controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with …
…, HA Schneier, CB Kurtz, JM Johnston - Official journal of the …, 2012 - journals.lww.com
OBJECTIVES: Linaclotide is a minimally absorbed guanylate cyclase-C agonist. The objective
of this trial was to determine the efficacy and safety of linaclotide in patients with irritable …
of this trial was to determine the efficacy and safety of linaclotide in patients with irritable …
Chiral proton catalysis: a catalytic enantioselective direct aza-Henry reaction
BM Nugent, RA Yoder, JN Johnston - Journal of the American …, 2004 - ACS Publications
Despite Nature's longstanding ability to use a proton, the most prevalent Lewis acid, to both
activate and orient a substrate during an enantioselective reaction, this work represents the …
activate and orient a substrate during an enantioselective reaction, this work represents the …
[HTML][HTML] Two randomized trials of linaclotide for chronic constipation
…, P Eng, SM Fox, JM Johnston - … England Journal of …, 2011 - Mass Medical Soc
Background Linaclotide is a minimally absorbed peptide agonist of the guanylate cyclase C
receptor. In two trials, we aimed to determine the efficacy and safety of linaclotide in patients …
receptor. In two trials, we aimed to determine the efficacy and safety of linaclotide in patients …
High conservation of transcription factor binding and evidence for combinatorial regulation across six Drosophila species
Q He, AF Bardet, B Patton, J Purvis, J Johnston… - Nature …, 2011 - nature.com
The binding of some transcription factors has been shown to diverge substantially between
closely related species. Here we show that the binding of the developmental transcription …
closely related species. Here we show that the binding of the developmental transcription …